Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.
Introduced First Reading Assembly Referred to AFI
Email me when A 5784 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 5784. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill requires any pharmacist or the pharmacist’s designee to notify the consumer when the medication they receive is a substitute for the prescribed drug or biological product. It applies to all pharmacy transactions in New Jersey and is intended to increase transparency for patients about what they are taking.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 5784
3 free questions a day, no accountSponsors
- Roy Freiman (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 5784 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 5784 freeOr ask your AI assistant about A 5784 directly:
Add to Claude, ChatGPT or Cursor